Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malaria | D008288 | EFO_0001068 | B54 | — | 2 | — | — | — | 2 |
Falciparum malaria | D016778 | EFO_0007444 | B50 | — | 1 | — | — | — | 1 |
Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | — | 1 |
Communicable diseases | D003141 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Drug common name | CABAMIQUINE |
INN | cabamiquine |
Description | Cabamiquine is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target elongation factor 2. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(NCCN1CCCC1)c1cc(-c2ccc(CN3CCOCC3)cc2)nc2ccc(F)cc12 |
PDB | — |
CAS-ID | 1469439-69-7 |
RxCUI | — |
ChEMBL ID | CHEMBL4091762 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | E3OC1CU1F4 (ChemIDplus, GSRS) |